ドパミン作動薬調節下におけるパーキンソン病の機能的神経協調を明らかにする動的神経シナジー
Jiewei Lu1,2,3, Yuanyuan Cheng4, Xinyuan Zhang1
1College of Artificial Intelligence, Nankai University, Tianjin, 300350, People's Republic of China.
Journal of neuroengineering and rehabilitation
|January 31, 2026
まとめ
動的神経シナジー、新しい指標はパーキンソン病治療により正常化された。このアプローチは、従来の機能的接続法とは異なり、早期診断と個別化治療のための新しいバイオマーカーを提供する。
科学分野:
- 神経科学
- システム神経科学
- 計算神経科学
背景:
- 神経シナジーと冗長性は、従来の機能的接続(FC)を超えた神経機能に関する洞察を提供する。
- これらの高次の神経的側面は、パーキンソン病(PD)では十分に探求されていない。
- 動的解析は、PDの神経的基盤を調査するために不可欠である。
主な方法:
- 神経シナジーと冗長性を定量化するために、動的情報分解フレームワークを開発した。
- このフレームワークを、歩行状態の機能的近赤外分光法(fNIRS)データに適用した。
- ドパミン作動薬治療を受けている63人のパーキンソン病患者と36人の健常対照群のデータを解析した。
結論:
- 動的神経シナジーは、パーキンソン病における神経ダイナミクスに関する高度な視点を提供する。
- この指標は、パーキンソン病の高次の機能的バイオマーカーを明らかにする可能性を秘めている。
- パーキンソン病の早期診断と個別化治療戦略への応用が期待される。
関連する概念動画
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Brainstem
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


